Shares of N4 Pharma Plc (LON:N4P – Get Free Report) shot up 8.3% during mid-day trading on Wednesday . The company traded as high as GBX 0.65 ($0.01) and last traded at GBX 0.65 ($0.01). 230,214 shares changed hands during trading, a decline of 81% from the average session volume of 1,197,753 shares. The stock had previously closed at GBX 0.60 ($0.01).
N4 Pharma Price Performance
The firm has a market capitalization of £2.37 million, a P/E ratio of -55.00 and a beta of -0.37. The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62. The firm has a 50 day moving average price of GBX 0.64 and a 200-day moving average price of GBX 0.58.
About N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Featured Articles
- Five stocks we like better than N4 Pharma
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Financial Services Stocks Investing
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
